Global Electrocardiograph (ECG) Market 2021-2031 by Product Type (Conventional Devices, Emerging Devices, Software & Services), Lead Type (Single-lead, 3-lead, 5-lead, 6-lead, 12-lead), Function (Diagnostic, Monitoring), Technology (Portable, Wireless), End User (Hospitals and Clinics, ASCs, Home-based Users, Cardiac Centers), and Region: Trend Forecast and Growth Opportunity
Global electrocardiograph (ECG) market will reach $ 13,291.3 million by 2031, growing by 6.4% annually over 2021-2031, driven by the rising incidences of cardiac disorders and lifestyle related diseases, constantly increasing incidences of casualties due to cardiovascular diseases (CVDs), the increase in geriatric population coupled with behavioral risk factors such as rise in alcohol consumption and smoking, technological advancement and innovations, and the increasing healthcare expenditure.
Highlighted with 83 tables and 90 figures, this 175-page report “Global Electrocardiograph (ECG) Market 2021-2031 by Product Type (Conventional Devices, Emerging Devices, Software & Services), Lead Type (Single-lead, 3-lead, 5-lead, 6-lead, 12-lead), Function (Diagnostic, Monitoring), Technology (Portable, Wireless), End User (Hospitals and Clinics, ASCs, Home-based Users, Cardiac Centers), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global electrocardiograph (ECG) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global electrocardiograph (ECG) market in every aspect of the classification from perspectives of Product Type, Lead Type, Function, Technology, End User, and Region.
Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Conventional Devices
o Resting ECG Devices
o Stress ECG Devices
• Emerging Devices
o Implantable Loop Recorders
o Mobile Cardiac Telemetry
o Holter Monitors
o Cardiac Event Monitors
o Smart ECG Monitors
• Software & Services
Based on Lead Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Single-Lead Type ECG Devices
• 3-Lead Type ECG Devices
• 5-Lead Type ECG Devices
• 6-Lead Type ECG Devices
• 12-Lead Type ECG Devices
• Other Lead Types
By Function, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Diagnostic ECG Systems
• Monitoring ECG Systems
By Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Portable ECG Systems
• Wireless ECG Systems
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Home-based Users
• Cardiac Centers
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Product Type, Lead Type and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
ACS Diagnostics
Biotricity, Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
CardioComm Solutions, Inc.
Cardioline SpA
Edan Instruments, Inc.
Fukuda Denshi Co., Ltd.
General Electric Company
Hill-Rom Holdings, Inc.
iRhythm Technologies, Inc.
Koninklijke Philips N.V.
Medtronic plc
Mindray Medical International Limited
Nihon Kohden Corporation
OSI Systems, Inc.
Schiller AG
Suzuken Co., Ltd.
Zoll Medical Corporation (Asahi Kasei Corporation)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porter’s Fiver Forces Analysis 40
3 Segmentation of Global Market by Product Type 44
3.1 Market Overview by Product Type 44
3.2 Conventional Devices 46
3.2.1 Resting ECG Devices 47
3.2.2 Stress ECG Devices 48
3.3 Emerging Devices 49
3.3.1 Implantable Loop Recorders 51
3.3.2 Mobile Cardiac Telemetry 52
3.3.3 Holter Monitors 53
3.3.4 Cardiac Event Monitors 54
3.3.5 Smart ECG Monitors 55
3.4 Software & Services 56
4 Segmentation of Global Market by Lead Type 57
4.1 Market Overview by Lead Type 57
4.2 Single-Lead Type ECG Devices 59
4.3 3-Lead Type ECG Devices 60
4.4 5-Lead Type ECG Devices 61
4.5 6-Lead Type ECG Devices 62
4.6 12-Lead Type ECG Devices 63
4.7 Other Lead Types 64
5 Segmentation of Global Market by Function 65
5.1 Market Overview by Function 65
5.2 Diagnostic ECG Systems 67
5.3 Monitoring ECG Systems 68
6 Segmentation of Global Market by Technology 69
6.1 Market Overview by Technology 69
6.2 Portable ECG Systems 71
6.3 Wireless ECG Systems 72
7 Segmentation of Global Market by End User 73
7.1 Market Overview by End User 73
7.2 Hospitals and Clinics 75
7.3 Ambulatory Surgical Centers (ASCs) 76
7.4 Home-based Users 77
7.5 Cardiac Centers 78
7.6 Other End Users 79
8 Segmentation of Global Market by Region 80
8.1 Geographic Market Overview 2021-2031 80
8.2 North America Market 2021-2031 by Country 84
8.2.1 Overview of North America Market 84
8.2.2 U.S. 88
8.2.3 Canada 91
8.2.4 Mexico 93
8.3 European Market 2021-2031 by Country 95
8.3.1 Overview of European Market 95
8.3.2 Germany 99
8.3.3 U.K. 101
8.3.4 France 103
8.3.5 Spain 105
8.3.6 Italy 107
8.3.7 Russia 109
8.3.8 Rest of European Market 111
8.4 Asia-Pacific Market 2021-2031 by Country 113
8.4.1 Overview of Asia-Pacific Market 113
8.4.2 Japan 117
8.4.3 China 120
8.4.4 Australia 122
8.4.5 India 124
8.4.6 South Korea 126
8.4.7 Rest of APAC Region 128
8.5 South America Market 2021-2031 by Country 130
8.5.1 Argentina 133
8.5.2 Brazil 135
8.5.3 Chile 137
8.5.4 Rest of South America Market 139
8.6 MEA Market 2021-2031 by Country 140
8.6.1 UAE 143
8.6.2 Saudi Arabia 145
8.6.3 South Africa 147
8.6.4 Other National Markets 149
9 Competitive Landscape 150
9.1 Overview of Key Vendors 150
9.2 New Product Launch, Partnership, Investment, and M&A 153
9.3 Company Profiles 154
Abbott Laboratories 154
ACS Diagnostics 156
Biotricity, Inc. 157
BIOTRONIK SE & Co. KG 158
Boston Scientific Corporation 159
CardioComm Solutions, Inc. 160
Cardioline SpA 161
Edan Instruments, Inc. 162
Fukuda Denshi Co., Ltd. 163
General Electric Company 164
Hill-Rom Holdings, Inc. 165
iRhythm Technologies, Inc. 166
Koninklijke Philips N.V. 167
Medtronic plc 168
Mindray Medical International Limited 169
Nihon Kohden Corporation 170
OSI Systems, Inc. 171
Schiller AG 172
Suzuken Co., Ltd. 173
Zoll Medical Corporation (Asahi Kasei Corporation) 174
RELATED REPORTS 175